Company

Product

Description

Indication

Status

Aerie Pharmaceuticals Inc., of Durham, N.C.

Rocklatan (netarsudil and latanoprost ophthalmic solution)

Eye drop combination of Rho kinase inhibitor and prostaglandin

Reducing intraocular pressure in open-angle glaucoma or ocular hypertension

Submitted a prior approval supplement to FDA seeking to produce Rocklatan in a new manufacturing plant in Athlone, Ireland

Partner Therapeutics Inc., of Lexington, Mass.

Leukine (sargramostim)

Yeast-derived recombinant human GM-CSF

Stage IIB-IV melanoma

FDA granted orphan designation

Sanbio Group, of Mountain View, Calif.

SB-623

Cell therapy

Chronic neurological motor deficits secondary to traumatic brain injury

FDA granted regenerative medicine advanced therapy designation

Shenzhen Chipscreen Biosciences Ltd., of Shenzhen, China

Chiglitazar

Non-TZD PPAR alpha/gamma/delta pan-agonist

Type 2 diabetes

NDA accepted by center for drug evaluation at China's NMPA

Notes

For more information about individual companies and/or products, see Cortellis.

 

No Comments